MRKR – Marker Therapeutics Inc
Float Short %
1.89
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.1
EPS Last/This Y
0.26
EPS This/Next Y
0.14
Price
1.45
Target Price
7.87
Analyst Recom
1
Performance Q
43.56
Upside
-1,202.8%
Beta
1.42
Ticker: MRKR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | MRKR | 2.13 | N/A | N/A | 0 |
| 2026-01-26 | MRKR | 1.88 | N/A | N/A | 0 |
| 2026-01-27 | MRKR | 1.8 | N/A | N/A | 0 |
| 2026-01-28 | MRKR | 1.62 | N/A | N/A | 0 |
| 2026-01-29 | MRKR | 1.61 | N/A | N/A | 0 |
| 2026-01-30 | MRKR | 1.6 | N/A | N/A | 0 |
| 2026-02-02 | MRKR | 1.71 | N/A | N/A | 0 |
| 2026-02-03 | MRKR | 1.88 | N/A | N/A | 0 |
| 2026-02-04 | MRKR | 1.84 | N/A | N/A | 0 |
| 2026-02-05 | MRKR | 1.665 | N/A | N/A | 0 |
| 2026-02-06 | MRKR | 1.65 | N/A | N/A | 0 |
| 2026-02-09 | MRKR | 1.48 | N/A | N/A | 0 |
| 2026-02-10 | MRKR | 1.57 | N/A | N/A | 0 |
| 2026-02-11 | MRKR | 1.5 | N/A | N/A | 0 |
| 2026-02-12 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-02-13 | MRKR | 1.45 | N/A | N/A | 0 |
| 2026-02-17 | MRKR | 1.447 | N/A | N/A | 0 |
| 2026-02-18 | MRKR | 1.495 | N/A | N/A | 0 |
| 2026-02-20 | MRKR | 1.46 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | MRKR | 2.12 | 54.8 | - | -0.94 |
| 2026-01-26 | MRKR | 1.86 | 54.8 | - | -0.94 |
| 2026-01-27 | MRKR | 1.83 | 54.8 | - | -0.94 |
| 2026-01-28 | MRKR | 1.62 | 54.8 | - | -0.94 |
| 2026-01-29 | MRKR | 1.61 | 54.8 | - | -0.94 |
| 2026-01-30 | MRKR | 1.61 | 54.8 | - | -0.94 |
| 2026-02-02 | MRKR | 1.72 | 54.8 | - | -0.94 |
| 2026-02-03 | MRKR | 1.86 | 54.8 | - | -0.94 |
| 2026-02-04 | MRKR | 1.83 | 54.8 | - | -0.94 |
| 2026-02-05 | MRKR | 1.66 | 54.8 | - | -0.94 |
| 2026-02-06 | MRKR | 1.65 | 54.8 | - | -0.94 |
| 2026-02-09 | MRKR | 1.49 | 54.8 | - | -0.94 |
| 2026-02-10 | MRKR | 1.57 | 54.8 | - | -0.94 |
| 2026-02-11 | MRKR | 1.50 | 54.8 | - | -0.94 |
| 2026-02-12 | MRKR | 1.43 | 54.8 | - | -0.94 |
| 2026-02-13 | MRKR | 1.43 | 54.8 | - | -0.94 |
| 2026-02-17 | MRKR | 1.44 | 54.8 | - | -0.94 |
| 2026-02-18 | MRKR | 1.49 | 54.8 | - | -0.94 |
| 2026-02-19 | MRKR | 1.50 | 54.8 | - | -0.94 |
| 2026-02-20 | MRKR | 1.45 | 54.8 | - | -0.94 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | MRKR | 0.00 | 0.40 | 2.41 |
| 2026-01-26 | MRKR | 0.00 | 0.40 | 2.41 |
| 2026-01-27 | MRKR | 0.00 | 0.40 | 2.41 |
| 2026-01-28 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-01-29 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-01-30 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-02-02 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-02-03 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-02-04 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-02-05 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-02-06 | MRKR | 0.00 | 0.40 | 2.29 |
| 2026-02-10 | MRKR | 0.00 | 2.65 | 2.29 |
| 2026-02-11 | MRKR | 0.00 | 2.65 | 1.89 |
| 2026-02-12 | MRKR | 0.00 | 2.65 | 1.89 |
| 2026-02-13 | MRKR | 0.00 | 2.65 | 1.89 |
| 2026-02-17 | MRKR | 0.00 | 3.86 | 1.89 |
| 2026-02-18 | MRKR | 0.00 | 3.86 | 1.89 |
| 2026-02-19 | MRKR | 0.00 | 3.86 | 1.89 |
| 2026-02-20 | MRKR | 0.00 | 3.86 | 1.89 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.12
Avg. EPS Est. Current Quarter
-0.19
Avg. EPS Est. Next Quarter
-0.22
Insider Transactions
Institutional Transactions
3.86
Beta
1.42
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
20
Growth Score
21
Sentiment Score
47
Actual DrawDown %
96
Max Drawdown 5-Year %
-98
Target Price
7.87
P/E
Forward P/E
PEG
P/S
5.15
P/B
1.31
P/Free Cash Flow
EPS
-1.23
Average EPS Est. Cur. Y
-0.94
EPS Next Y. (Est.)
-0.79
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-304.54
Relative Volume
0.48
Return on Equity vs Sector %
-106.8
Return on Equity vs Industry %
-89.3
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading